Suzanne M. Torontali
Procter & Gamble
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Suzanne M. Torontali.
Environmental Health Perspectives | 2004
Jorge M. Naciff; Gary J. Overmann; Suzanne M. Torontali; Gregory J. Carr; Jay P. Tiesman; George P. Daston
The effect of the dietary background of phytoestrogens on the outcome of rodent bioassays used to identify and assess the reproductive hazard of endocrine-disrupting chemicals is controversial. Phytoestrogens, including genistein, daidzein, and coumestrol, are fairly abundant in soybeans and alfalfa, common ingredients of laboratory animal diets. These compounds are weak agonists for the estrogen receptor (ER) and, when administered at sufficient doses, elicit an estrogenic response in vivo. In this study, we assessed the potential estrogenic effects of dietary phytoestrogens at the gene expression level, together with traditional biologic end points, using estrogen-responsive tissues of the immature female rat. We compared the gene expression profile of the uterus and ovaries, as a pool, obtained using a uterotrophic assay protocol, from intact prepubertal rats fed a casein-based diet (free from soy and alfalfa) or a regular rodent diet (Purina 5001) containing soy and alfalfa. Estrogenic potency of the phytoestrogen-containing diet was determined by analyzing uterine wet weight gain, luminal epithelial cell height, and gene expression profile in the uterus and ovaries. These were compared with the same parameters evaluated in animals exposed to a low dose of a potent ER agonist [0.1 μg/kg/day 17α-ethynyl estradiol (EE) for 4 days]. Exposure to dietary phytoestrogens or to a low dose of EE did not advance vaginal opening, increase uterine wet weight, or increase luminal epithelial cell height in animals fed either diet. Although there are genes whose expression differs in animals fed the soy/alfalfa-based diet versus the casein diet, those genes are not associated with estrogenic stimulation. The expression of genes well known to be estrogen regulated, such as progesterone receptor, intestinal calcium-binding protein, and complement component 3, is not affected by consumption of the soy/alfalfa-based diet when assessed by microarray or quantitative reverse transcriptase–polymerase chain reaction analysis. Our results indicate that although diet composition has an impact on gene expression in uterus and ovaries, it does not contribute to the effects of an ER agonist.
Environmental Health Perspectives | 2005
Jorge M. Naciff; Brian D. Richardson; Kerry G. Oliver; M. Lynn Jump; Suzanne M. Torontali; Kenton Duane Juhlin; Gregory J. Carr; Jennifer R. Paine; Jay P. Tiesman; George P. Daston
Recently gene expression studies have been multiplied at an accelerated rate by the use of high-density microarrays. By assaying thousands of transcripts at a time, microarrays have led to the discovery of dozens of genes involved in particular biochemical processes, for example, the response of a tissue/organ to a given chemical with therapeutic or toxic properties. The next step in these studies is to focus on the response of a subset of relevant genes to verify or refine potential therapeutic or toxic properties. We have developed a sensitive, high-throughput gene expression assay for this purpose. In this assay, based on the Luminex xMAP system, carefully selected oligonucleotides were covalently linked to fluorescently coded microspheres that are hybridized to biotinylated cRNA followed by amplification of the signal, which results in a rapid, sensitive, multiplexed assay platform. Using this system, we have developed an RNA expression profiling assay specific for 17 estrogen-responsive transcripts and three controls. This assay can evaluate up to 100 distinct analytes simultaneously in a single sample, in a 96-well plate format. This system has improved sensitivity versus existing microsphere-based assays and has sensitivity and precision comparable with or better than microarray technology. We have achieved detection levels down to 1 amol, detecting rare messages in complex cRNA samples, using as little as 2.5 μg starting cRNA. This assay offers increased throughput with decreased costs compared with existing microarray technologies, with the trade-off being in the total number of transcripts that can be analyzed.
Toxicological Sciences | 2002
Jorge M. Naciff; M. Lynn Jump; Suzanne M. Torontali; Gregory J. Carr; Jay P. Tiesman; Gary J. Overmann; George P. Daston
Mutation Research | 2004
Ting Hu; David P. Gibson; Gregory J. Carr; Suzanne M. Torontali; Jay P. Tiesman; Joel G. Chaney; Marilyn J. Aardema
Toxicological Sciences | 2005
Jorge M. Naciff; Karla A. Hess; Gary J. Overmann; Suzanne M. Torontali; Gregory J. Carr; Jay P. Tiesman; Leslie M. Foertsch; Brian D. Richardson; Joel E. Martinez; George P. Daston
Toxicological Sciences | 2003
Jorge M. Naciff; Gary J. Overmann; Suzanne M. Torontali; Gregory J. Carr; Jay P. Tiesman; Brian D. Richardson; George P. Daston
Toxicological Sciences | 2007
Jorge M. Naciff; Gary J. Overmann; Suzanne M. Torontali; Gregory J. Carr; Zubin Sarosh Khambatta; Jay P. Tiesman; Brian D. Richardson; George P. Daston
Birth Defects Research Part B-developmental and Reproductive Toxicology | 2005
Jorge M. Naciff; Suzanne M. Torontali; Gary I. Overmann; Gregory J. Carr; Jay P. Tiesman; George P. Daston
Archive | 2004
Suzanne M. Torontali; Mary Lynn Jump; Kenton Duane Juhlin; Brian D. Richardson; Jay P. Tiesman; Jorge M. Naciff
Archive | 2008
Suzanne M. Torontali; Jorge M. Naciff; Kenton Duane Juhlin; Jay P. Tiesman